Patents by Inventor Robert Tjian

Robert Tjian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cell-type specific transcription factor
    Patent number: 5710025
    Abstract: The invention provides methods and compositions relating to human tata-binding protein associated factor 105 (hTAF.sub.II 105) and related nucleic acids. The proteins may be produced recombinantly from transformed host cells from the disclosed hTAF.sub.II 105 encoding nucleic acids or purified from human cells. The invention provides isolated hTAF.sub.II 105 hybridization probes and primers capable of specifically hybridizing with the disclosed hTAF.sub.II 105 gene, hTAF.sub.II 105-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.
    Type: Grant
    Filed: October 2, 1996
    Date of Patent: January 20, 1998
    Assignee: The Regents of the University of California
    Inventors: Rivka Dikstein, Robert Tjian
  • Tata-binding protein associated factor, nucleic acids
    Patent number: 5637686
    Abstract: TATA-binding protein associated factors, TAFs, nuclear proteins involved in RNA polymerase I, II, and III transcription, and nucleic acids encoding TAFs are disclosed. The disclosed methods and compositions find use in developing pharmaceuticals, diagnosis and therapy.
    Type: Grant
    Filed: May 9, 1996
    Date of Patent: June 10, 1997
    Assignee: The Regents of the University of California
    Inventors: Robert Tjian, Lucio Comai, Brian D. Dynlact, Timothy Hoey, Siegfried Ruppert, Naoko Tanese, Edith Wang, Robert O. J. Weinzierl
  • TATA-binding protein associated factors drug screens
    Patent number: 5534410
    Abstract: TATA-binding protein associated factors, TAFs, nuclear proteins involved in RNA polymerase I, II, and III transcription, and nucleic acids encoding TAFs are disclosed. The disclosed methods and compositions find use in developing pharmaceuticals, diagnosis and therapy.
    Type: Grant
    Filed: January 28, 1994
    Date of Patent: July 9, 1996
    Assignee: The Regents of the University of California
    Inventors: Robert Tjian, Lucio Comai, Brian D. Dynlacht, Timothy Hoey, Siegfried Ruppert, Naoko Tanese, Edith Wang, Robert O. J. Weinzierl